Jury In Sophos Trial Awards FNJN $15 million

By Lisa Thompson Finjan (NASDAQ:FNJN) won its trial against Sophos yesterday and was awarded $ 15 million for the life of the patents. This was at the high end of the range that an expert witness sug...

Finjan Holdings, Inc. (FNJN: null) | Venue Change

Mon, May 12, 2014 12:00 – Finjan Holdings, Inc. (FNJN: Nasdaq) – Venue Change – The symbol, FNJN, no longer trades on OTC Link. As of Mon, May 12, 2014, FNJN trades on Nasdaq. You m...